Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome

Advances in human oxytocin measurement: challenges and proposed solutions

(2022) Benjamin A. Tabak et al.   MOLECULAR PSYCHIATRY

Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction

(2021) Maithé Tauber et al.   Lancet Diabetes & Endocrinology

Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects

(2021) Mariana Rae et al.   BRITISH JOURNAL OF PHARMACOLOGY

A Comprehensive Review of Genetically Engineered Mouse Models for Prader-Willi Syndrome Research

(2021) Delf-Magnus Kummerfeld et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome

(2021) Felipe Correa da‐Silva et al.   JOURNAL OF NEUROENDOCRINOLOGY

SNORD116 and growth hormone therapy impact IGFBP7 in Prader–Willi syndrome

(2021) Sanaa Eddiry et al.   GENETICS IN MEDICINE

Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium

(2021) Lauren Schwartz et al.   Journal of Neurodevelopmental Disorders

Refining oxytocin therapy for autism: context is key

(2021) Charles L. Ford et al.   Nature Reviews Neurology

Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder

(2021) Linmarie Sikich et al.   NEW ENGLAND JOURNAL OF MEDICINE

Colocalization of Oxtr with Prader-Willi Syndrome transcripts in the trigeminal ganglion of neonatal mice

(2020) Radhika Vaidyanathan et al.   HUMAN MOLECULAR GENETICS

Neonatal CSF vasopressin concentration predicts later medical record diagnoses of autism spectrum disorder

(2020) Ozge Oztan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Exogenous effects of oxytocin in five psychiatric disorders: a systematic review, meta-analyses and a personalized approach through the lens of the social salience hypothesis

(2020) Leehe Peled-Avron et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Loss of MAGEL2 in Prader-Willi syndrome leads to decreased secretory granule and neuropeptide production

(2020) Helen Chen et al.   JCI Insight

Oxytocin in young children with Prader‐Willi syndrome: Results of a randomized, double‐blind, placebo‐controlled, crossover trial investigating 3 months of oxytocin

(2020) Layla Damen et al.   CLINICAL ENDOCRINOLOGY

Correction of vasopressin deficit in the lateral septum ameliorates social deficits of mouse autism model

(2020) Amélie M. Borie et al.   JOURNAL OF CLINICAL INVESTIGATION

Intranasal oxytocin versus placebo for hyperphagia and repetitive behaviors in children with Prader-Willi Syndrome: A randomized controlled pilot trial

(2020) Eric Hollander et al.   JOURNAL OF PSYCHIATRIC RESEARCH

A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism

(2019) Karen J. Parker et al.   Science Translational Medicine

Face processing and exploration of social signals in Prader-Willi syndrome: a genetic signature

(2019) Jimmy Debladis et al.   Orphanet Journal of Rare Diseases

Profiles and trajectories of impaired social cognition in people with Prader-Willi syndrome

(2019) Elisabeth M. Dykens et al.   PLoS One

Circuits for social learning: A unified model and application to Autism Spectrum Disorder

(2019) Marilena M. DeMayo et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Cognitive deficits in the Snord116 deletion mouse model for Prader-Willi syndrome

(2018) Anna Adhikari et al.   NEUROBIOLOGY OF LEARNING AND MEMORY

Systematic review and meta-analysis of reported adverse events of long-term intranasal oxytocin treatment for autism spectrum disorder

(2018) Qizheng Cai et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Arginine vasopressin in cerebrospinal fluid is a marker of sociality in nonhuman primates

(2018) Karen J. Parker et al.   Science Translational Medicine

Cerebrospinal Fluid Vasopressin and Symptom Severity in Children with Autism

(2018) Ozge Oztan et al.   ANNALS OF NEUROLOGY

Inactivation of Magel2 suppresses oxytocin neurons through synaptic excitation-inhibition imbalance

(2018) Tayfun Ates et al.   NEUROBIOLOGY OF DISEASE

Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery

(2017) Zhimin Song et al.   FRONTIERS IN NEUROENDOCRINOLOGY

Magel2 knockout mice manifest altered social phenotypes and a deficit in preference for social novelty

(2017) M. D. Fountain et al.   GENES BRAIN AND BEHAVIOR

Diagnoses and characteristics of autism spectrum disorders in children with Prader-Willi syndrome

(2017) Elisabeth M. Dykens et al.   Journal of Neurodevelopmental Disorders

Oxytocin and vasopressin neural networks: Implications for social behavioral diversity and translational neuroscience

(2017) Zachary V. Johnson et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

The Use of Oxytocin to Improve Feeding and Social Skills in Infants With Prader–Willi Syndrome

(2017) Maïthé Tauber et al.   PEDIATRICS

Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism

(2017) Karen J. Parker et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Promising effects of oxytocin on social and food-related behaviour in young children with Prader-Willi syndrome: a randomized, double-blind, controlled crossover trial

(2016) R.J. Kuppens et al.   CLINICAL ENDOCRINOLOGY

PCSK1 Mutations and Human Endocrinopathies: From Obesity to Gastrointestinal Disorders

(2016) Pieter Stijnen et al.   ENDOCRINE REVIEWS

Impaired prohormone processing: a grand unified theory for features of Prader-Willi syndrome?

(2016) Joseph Polex-Wolf et al.   JOURNAL OF CLINICAL INVESTIGATION

Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome

(2016) Lisa C. Burnett et al.   JOURNAL OF CLINICAL INVESTIGATION

Measuring Oxytocin and Vasopressin: Bioassays, Immunoassays and Random Numbers

(2016) G. Leng et al.   JOURNAL OF NEUROENDOCRINOLOGY

Vasopressin increases human risky cooperative behavior

(2016) Claudia Brunnlieb et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Plasma Oxytocin and Arginine-Vasopressin Levels in Children with Autism Spectrum Disorder in China: Associations with Symptoms

(2016) Hong-Feng Zhang et al.   Neuroscience Bulletin

Elevated plasma oxytocin levels in children with Prader-Willi syndrome compared with healthy unrelated siblings

(2015) Lisa Johnson et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism

(2015) Hamid Meziane et al.   BIOLOGICAL PSYCHIATRY

Behavioural characteristics of the Prader–Willi syndrome related biallelic Snord116 mouse model

(2015) Jerzy Zieba et al.   NEUROPEPTIDES

Prader–Willi syndrome: From genetics to behaviour, with special focus on appetite treatments

(2015) Joanne L. Griggs et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Oxytocin and vasopressin: linking pituitary neuropeptides and their receptors to social neurocircuits

(2015) Danielle A. Baribeau et al.   Frontiers in Neuroscience

A double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome

(2014) Stewart L. Einfeld et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders

(2014) S.M. Francis et al.   BRAIN RESEARCH

The vertebrate ancestral repertoire of visual opsins, transducin alpha subunits and oxytocin/vasopressin receptors was established by duplication of their shared genomic region in the two rounds of early vertebrate genome duplications

(2013) David Lagman et al.   BMC EVOLUTIONARY BIOLOGY

Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism

(2013) Christian P Schaaf et al.   NATURE GENETICS

Problems with measuring peripheral oxytocin: Can the data on oxytocin and human behavior be trusted?

(2013) Michael E. McCullough et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies

(2013) Gheorghe Doros et al.   STATISTICS IN MEDICINE

Prader-Willi syndrome

(2012) Suzanne B. Cassidy et al.   GENETICS IN MEDICINE

The regulation of social recognition, social communication and aggression: Vasopressin in the social behavior neural network

(2011) H. Elliott Albers   HORMONES AND BEHAVIOR

Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine

(2011) Andreas Meyer-Lindenberg et al.   NATURE REVIEWS NEUROSCIENCE

Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patients

(2011) Maïthe Tauber et al.   Orphanet Journal of Rare Diseases

Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome

(2011) Scott S. Hall et al.   PSYCHONEUROENDOCRINOLOGY

Effects of intranasal oxytocin and vasopressin on cooperative behavior and associated brain activity in men

(2011) James K. Rilling et al.   PSYCHONEUROENDOCRINOLOGY

Evaluation of Enzyme Immunoassay and Radioimmunoassay Methods for the Measurement of Plasma Oxytocin

(2011) Angela Szeto et al.   PSYCHOSOMATIC MEDICINE

Intranasal Arginine Vasopressin Enhances the Encoding of Happy and Angry Faces in Humans

(2010) Adam J. Guastella et al.   BIOLOGICAL PSYCHIATRY

Endocrine Disorders in Children with Prader-Willi Syndrome – Data from 142 Children of the French Database

(2010) G. Diene et al.   Hormone Research in Paediatrics

A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene

(2010) Fabienne Schaller et al.   HUMAN MOLECULAR GENETICS

Promoting social behavior with oxytocin in high-functioning autism spectrum disorders

(2010) E. Andari et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism

(2009) A. J. de Smith et al.   HUMAN MOLECULAR GENETICS

Oxytocin Makes a Face in Memory Familiar

(2009) U. Rimmele et al.   JOURNAL OF NEUROSCIENCE

The effect of intranasal administration of oxytocin on fear recognition

(2009) M. Fischer-Shofty et al.   NEUROPSYCHOLOGIA

Loss of Magel2, a Candidate Gene for Features of Prader-Willi Syndrome, Impairs Reproductive Function in Mice

(2009) Rebecca E. Mercer et al.   PLoS One

Oxytocin Enhances the Encoding of Positive Social Memories in Humans

(2008) Adam J. Guastella et al.   BIOLOGICAL PSYCHIATRY

Nescient Helix-Loop-Helix 2 Interacts with Signal Transducer and Activator of Transcription 3 to Regulate Transcription of Prohormone Convertase 1/3

(2008) Dana L. Fox et al.   MOLECULAR ENDOCRINOLOGY

Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster

(2008) Trilochan Sahoo et al.   NATURE GENETICS

Oxytocin Shapes the Neural Circuitry of Trust and Trust Adaptation in Humans

(2008) Thomas Baumgartner et al.   NEURON

SnoRNA Snord116 (Pwcr1/MBII-85) Deletion Causes Growth Deficiency and Hyperphagia in Mice

(2008) Feng Ding et al.   PLoS One

Oxytocin, Vasopressin, and the Neurogenetics of Sociality

(2008) Z. R. Donaldson et al.   SCIENCE

Oxytocin Increases Gaze to the Eye Region of Human Faces

(2007) Adam J. Guastella et al.   BIOLOGICAL PSYCHIATRY